Ra Capital Management, L.P. Silverback Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	1,401,299 Added 14.81%	10,860,977 $0
Q4 2023 Feb 14, 2024	BUY	N/A	9,459,678 New	9,459,678 $0
Q3 2023 Nov 14, 2023	BUY	N/A	6,450,000 Added 214.31%	9,459,678 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $6.07 $0 - $18.3 Million	3,009,678 New	3,009,678 $0
Q1 2022 May 16, 2022	SELL	$3.51 - $6.74 $6.12 Million - $11.7 Million	-1,742,186 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$25.0 - $46.34 $43.6 Million - $80.7 Million	1,742,186 New	1,742,186 $80.7 Million

117

47.9M

442K

42K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.